Bcr-Abl inhibitor PD173955, Purity ≥98%

Cat. No.: X24-06-ZQ497

Bcr-Abl inhibitor PD173955, Purity ≥98%

Synonym: 260415-63-2; Bcr-Abl inhibitor; PD 173955; PD-173955

  • CAS Number: 260415-63-2
  • Compound CID: 447077
Product Size
5 mg; 10 mg; 25 mg; 50 mg
Price
Datasheet
MSDS
Properties
Description
PD173955, soluble in warmed DMSO and insoluble in water and ethanol, specifically inhibits the activity of the Bcr-Abl tyrosine kinase. It targets Bcr-Abl and Src.
Molecular Weight
443.35
Molecular Formula
C21H16Cl2N4OS
Targets
Bcr-Abl: 1-2 nM; Src: 22 nM
Form
Lyophilized powder
Purity
≥98%
Solubility
Warmed DMSO: 13 mg/mL (29.32 mM); Water: Insoluble; Ethanol: Insoluble
Identity
Confirmed by NMR/HPLC/MS.
Applications
PD173955 targets Bcr-Abl, investigated for its efficacy in treating leukemia.
Related Products

Christmas 2024

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0